NCT03193593View on ClinicalTrials.gov

Study to Evaluate EB-001 in Reducing Musculoskeletal Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

April 26, 2018

Study Completion Date

August 7, 2018

Conditions
Musculoskeletal Pain
Interventions
DRUG

Placebo

Placebo- Single injection of saline into Pectoralis Muscle

DRUG

EB-001

Single injection of EB-001 into Pectoralis Muscle

Trial Locations (1)

91105

Lotus Clinical Research, Pasadena

All Listed Sponsors
lead

Bonti, Inc.

INDUSTRY

NCT03193593 - Study to Evaluate EB-001 in Reducing Musculoskeletal Pain | Biotech Hunter | Biotech Hunter